Loading...
Symbols:
Loading...
Symbols:
Momenta Pharmaceuticals Inc. (MNTA)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on Momenta Pharmaceuticals Inc. (MNTA)
16 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on MNTA
- Mike Havrilla(8)
- Bespoke Investment Group(3)
- Centient Biotech Investor(1)
- Andrew Vaino(1)
- Notable Calls(1)
Most popular authors
(tracked in watchlists)
- Bespoke Investment Group(528)
- Andrew Wilkinson(297)
- Notable Calls(112)
- Mike Havrilla(79)
- Centient Biotech Investor(3)
Most commented on authors
- Teva Beats On Profits
- Four Biotechs at Attractive Entry Points
- Generic Drug Industry Outperforms Drug and Healthcare ETFs
- Overview and Analysis of the Global Generic Drug Industry
- Momenta Pharma Investors In Waiting Game on Enoxaparin
- Pharmaceuticals: Near Term Movers Based On FDA Decision Dates
- Momenta Pharma: A Waiting Game
- FDA Calendar: Cardiome, Momenta, Discovery Labs, Introgen
- Best and Worst Performing Stocks Seven Months Into 2008
- Another Month of '08 in the Books
- Wednesday's Options Report: C, V, BCO, VLO, CBI, MNTA, CLX
- Momenta Pharma: Expect Upside Following Game-Changing Upgrade
- Q1's Best and Worst Performing Stocks
- The Next Great Biotech Short Squeeze
- Is Momenta's Stock Plunge Justified?
- Biotech Day In Review: Sanofi Loses Lovenox Patent
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »